2025-2026 Regular Session • New York Legislature
A02289
Legislative Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/16/2025
referred to consumer affairs and protection
Assembly
5/22/2025
amend and recommit to consumer affairs and protection
Assembly
5/22/2025
print number 2289a
Assembly
Status Information
Current Status
Introduced(1/16/2025)
Chamber
Assembly
Committee
Consumer Affairs and Protection(Assembly)
Sponsors
Democrat: 25
Republican: 1
Primary Sponsor
Emily Gallagher
Democrat
Co-Sponsors (25)
Albert Stirpe
Democrat
Phara Souffrant Forrest
Democrat
Zohran Kwame Mamdani
Democrat
Steve Stern
Democrat
Jessica Gonzalez-Rojas
Democrat
Jo Simon
Democrat
Maryjane Shimsky
Democrat
William Colton
Democrat
Karines Reyes
Democrat
Tony Simone
Democrat
Steven Raga
Democrat
Sarahana Shrestha
Democrat
Rebecca Seawright
Democrat
Philip Ramos
Democrat
Linda Rosenthal
Democrat
Maritza Davila
Democrat
Sarah Clark
Democrat
Donna Lupardo
Democrat
Keith Brown
Republican
Harvey Epstein
Democrat
Angelo Santabarbara
Democrat
Gabriella Romero
Democrat
Anna Kelles
Democrat
Jonathan Jacobson
Democrat
Micah Lasher
Democrat